Study Of 6 Vs. 12 Months Of Her2 Medicine After Breast Cancer Surgery
Seeking adults with HER2-positive breast cancer who finished chemotherapy plus trastuzumab and breast surgery, and had no cancer found at surgery. This study compares 6 months to 12 months of HER2 medicine to keep cancer from coming back.